Will FDA advisers recommend a multi-cancer blood test for approval? They'll vote
The company Grail says its Galleri blood test can detect up to 50 forms of cancer. An independent panel of experts will decide if the test should be recommended for FDA approval.
We haven't written up this one. NPR Health has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.